August 6, 2009
Recent News
View All
Tuesday, February 16, 2010
EntreMed Receives Orphan Drug Designation for ENMD-2076 in Leukemia
Thursday, February 4, 2010
EntreMed Raises Additional $2.5 Million in Registered Direct Offering
Wednesday, January 20, 2010
EntreMed Receives NASDAQ Staff Determination Letter Regarding Non-Compliance with Minimum Bid Price Rule and Requests Hearing
Tuesday, January 12, 2010
EntreMed Completes Registered Direct Offering of $2.5 Million in Common Stock
Friday, December 11, 2009
EntreMed Reports Receipt of Third Quarter Royalty Payment
Stay Informed
Enter your e-mail address to receive press releases electronically. (Manage your subscription)